Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Trading Down 0.1% – Time to Sell?

Shionogi & Co., Ltd. (OTCMKTS:SGIOY)’s stock price dropped 0.1% during trading on Monday . The stock traded as low as $7.44 and last traded at $7.46. Approximately 52,526 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 181,511 shares. The stock had previously closed at $7.47.

Shionogi & Co., Ltd. Stock Performance

The company’s 50-day moving average price is $7.10 and its 200 day moving average price is $8.14. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.01 and a current ratio of 7.64. The stock has a market capitalization of $12.69 billion, a PE ratio of 12.37, a PEG ratio of 2.37 and a beta of 0.23.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) last posted its earnings results on Friday, January 31st. The company reported $0.16 EPS for the quarter. Shionogi & Co., Ltd. had a net margin of 35.53% and a return on equity of 12.02%. On average, equities research analysts expect that Shionogi & Co., Ltd. will post 0.66 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Company Profile

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.